Control of vascular permeability by adhesion molecules

Tissue Barriers

Volumn 3, Issue 1, 2015, Pages

  Sarelius, Ingrid H ^a   Glading, Angela J ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Adhesion; Endothelial barrier function; ICAM 1; Integrins; PECAM 1; Permeability; Transendothelial migration; VE cadherin

Indexed keywords

ALBUMIN; ALPHA ACTININ; BETA ARRESTIN 2; BETA CATENIN; CADHERIN; CAVEOLIN 1; CD31 ANTIGEN; CELL ADHESION MOLECULE; CILENGITIDE; FIBRONECTIN; FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTEGRIN LINKED KINASE; INTERCELLULAR ADHESION MOLECULE 1; P21 ACTIVATED KINASE; PAXILLIN; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PROTEIN P120; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASODILATOR STIMULATED PHOSPHOPROTEIN; WNT1 PROTEIN;

BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CELL PROLIFERATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; PERMEABILITY BARRIER; PHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 84962876448     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/21688370.2014.985954     Document Type: Review

References (132)

1. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7:803-15; PMID:17893694; http://dx.doi.org/10.1038/nri2171.
2. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009; 11:e19; PMID:19563700; http://dx.doi.org/10.1017/S1462399409001112.
3. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009; 16:209-21; PMID:19217423; http://dx.doi.org/10.1016/j.devcel.2009.01.004.
4. Pokutta S, Choi HJ, Ahlsen G, Hansen SD, Weis WI. Structural and thermodynamic characterization of cadherin.beta-catenin.alpha-catenin complex formation. J Biol Chem 2014; 289:13589-601; PMID:24692547; http://dx.doi.org/10.1074/jbc.M114.554709.
5. Desai R, Sarpal R, Ishiyama N, Pellikka M, Ikura M, Tepass U. Monomeric alpha-catenin links cadherin to the actin cytoskeleton. Nat Cell Biol 2013; 15:261-73; PMID:23417122; http://dx.doi.org/10.1038/ncb2685.
6. Heemskerk N, van Rijssel J, van Buul JD. Rho-GTPase signaling in leukocyte extravasation: An endothelial point of view. Cell Adh Migr 2014; 8:67-75; PMID:24621576; http://dx.doi.org/10.4161/cam.28244.
7. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009; 77:39-45; PMID:18973762; http://dx.doi.org/10.1016/j.mvr.2008.09.005.
8. Schlegel N, Waschke J. VASP is involved in cAMPmediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 2009; 296: C453-62; PMID:19118163; http://dx.doi.org/10.1152/ajpcell.00360.2008.
9. Spindler V, Peter D, Harms GS, Asan E, Waschke J. Ultrastructural analysis reveals cAMP-dependent enhancement of microvascular endothelial barrier functions via Rac1-mediated reorganization of intercellular junctions. Am J Pathol 2011; 178:2424-36; PMID:21457935; http://dx.doi.org/10.1016/j.ajpath.2011.01.014.
10. Alom-Ruiz SP, Anilkumar N, Shah AM. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008; 10:1089-100; PMID:18315494; http://dx.doi.org/10.1089/ars.2007.2007.
11. Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl) 2013; 91:323-8; PMID:23430240; http://dx.doi.org/10.1007/s00109-013-1007-3.
12. Gavard J, Gutkind J. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006; 8:1223-34; PMID:17060906; http://dx.doi.org/10.1038/ncb1486.
13. Zhang Y, Zhang L, Li Y, Sun S, Tan H. Different contributions of clathrin-and caveolae-mediated endocytosis of vascular endothelial cadherin to lipopolysaccharide-induced vascular hyperpermeability. PLoS One 2014; 9:e106328; PMID:25180771; http://dx.doi.org/10.1371/journal.pone.0106328.
14. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005; 280:31906-12; PMID:16027153; http://dx.doi.org/10.1074/jbc.M505568200.
15. Sidibe A, Polena H, Pernet-Gallay K, Razanajatovo J, Mannic T, Chaumontel N, Bama S, Marechal I, Huber P, Gulino-Debrac D, et al. VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs. Am J Physiol Heart Circ Physiol 2014; 307:H455-63; PMID:24858856; http://dx.doi.org/10.1152/ajpheart.00774.2013.
16. Vandenbroucke St Amant E, Tauseef M, Vogel SM, Gao XP, Mehta D, Komarova YA, Malik AB. PKCalpha activation of p120-catenin serine 879 phosphoswitch disassembles VE-cadherin junctions and disrupts vascular integrity. Circ Res 2012; 111:739-49; PMID:22798526; http://dx.doi.org/10.1161/CIRCRESAHA.112.269654.
17. Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M. Regulation of E-cadherinCatenin association by tyrosine phosphorylation. J Biol Chem 1999; 274:36734-40; PMID:10593980; http://dx.doi.org/10.1074/jbc.274.51.36734.
18. Rhee J, Mahfooz NS, Arregui C, Lilien J, Balsamo J, VanBerkum MF. Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion. Nat Cell Biol 2002; 4:798-805; PMID:12360290; http://dx.doi.org/10.1038/ncb858.
19. Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Duñach M. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and betacatenin-alpha-catenin Interaction. Mol Cell Biol 2003; 23:2287-97; PMID:12640114; http://dx.doi.org/10.1128/MCB.23.7.2287-2297.2003.
20. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. Embo J 2002; 21:4885-95; PMID:12234928; http://dx.doi.org/10.1093/emboj/cdf497.
21. Wessel F, Winderlich M, Holm M, Frye M, Rivera-Galdos R, Vockel M, Linnepe R, Ipe U, Stadtmann A, Zarbock A, et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol 2014; 15:223-30; PMID:24487320; http://dx.doi.org/10.1038/ni.2824.
22. Holsinger LJ, Ward K, Duffield B, Zachwieja J, Jallal B. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). Oncogene 2002; 21:7067-76; PMID:12370829; http://dx.doi.org/10.1038/sj.onc.1205858.
23. Nejsum LN, Nelson WJ. A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity. J Cell Biol 2007; 178:323-35; PMID:17635938; http://dx.doi.org/10.1083/jcb.200705094.
24. Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell 2007; 128:547-60; PMID:17289573; http://dx.doi.org/10.1016/j.cell.2006.12.037.
25. Fujito T, Ikeda W, Kakunaga S, Minami Y, Kajita M, Sakamoto Y, Monden M, Takai Y. Inhibition of cell movement and proliferation by cell-cell contactinduced interaction of Necl-5 with nectin-3. J Cell Biol 2005; 171:165-73; PMID:16216929; http://dx.doi.org/10.1083/jcb.200501090.
26. Sakamoto Y, Ogita H, Komura H, Takai Y. Involvement of nectin in inactivation of integrin alpha(v)beta (3) after the establishment of cell-cell adhesion. J Biol Chem 2008; 283:496-505; PMID:17965016; http://dx.doi.org/10.1074/jbc.M704195200.
27. Stupack D, Cheresh D. ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci STKE 2002; 2002:PE7; PMID:11842241.
28. Weis SM, Cheresh DA. alphaV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med 2011; 1:a006478; PMID:22229119; http://dx.doi.org/10.1101/cshperspect.a006478.
29. Rüuegg C, Mariotti A. Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 2003; 60:1135-57; PMID:12861381.
30. Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 2007; 101:570-80; PMID:17641225; http://dx.doi.org/10.1161/CIRCRESAHA.107.155655.
31. Zaric J, Ruegg C. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem 2005; 280:1077-85; PMID:15525653; http://dx.doi.org/10.1074/jbc.M410006200.
32. Su G, Atakilit A, Li JT, Wu N, Bhattacharya M, Zhu J, Shieh JE, Li E, Chen R, Sun S, et al. Absence of integrin alphavbeta3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med 2012; 185:58-66; PMID:21980034; http://dx.doi.org/10.1164/rccm.201108-1381OC.
33. Robinson SD, Reynolds LE, Wyder L, Hicklin DJ, Hodivala-Dilke KM. Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler Thromb Vasc Biol 2004; 24:2108-14; PMID:15345507; http://dx.doi.org/10.1161/01.ATV.0000143857.27408.de.
34. Curtis TM, McKeown-Longo PJ, Vincent PA, Homan SM, Wheatley EM, Saba TM. Fibronectin attenuates increased endothelial monolayer permeability after RGD peptide, anti-alpha 5 beta 1, or TNFalpha exposure. Am J Physiol 1995; 269:L248-60; PMID:7544537.
35. Su G, Hodnett M, Wu N, Atakilit A, Kosinski C, Godzich M, Huang XZ, Kim JK, Frank JA, Matthay MA, et al. Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function. Am J Respir Cell Mol Biol 2007; 36: 377-86; PMID:17079779; http://dx.doi.org/10.1165/rcmb.2006-0238OC.
36. Su G, Atakilit A, Li JT, Wu N, Luong J, Chen R, Bhattacharya M, Sheppard D. Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin alphavbeta5. Crit Care Med 2013; 41: 546-53; PMID:23263571; http://dx.doi.org/10.1097/CCM.0b013e3182711b1e.
37. Alghisi GC, Ponsonnet L, Ruegg C. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One 2009; 4:e4449; PMID:19212436; http://dx.doi.org/10.1371/journal.pone.0004449.
38. Milner R, Hung S, Erokwu B, Dore-Duffy P, LaManna JC, Del Zoppo GJ. Increased expression of fibronectin and the alpha 5 beta 1 integrin in angiogenic cerebral blood vessels of mice subject to hypobaric hypoxia. Mol Cell Neurosci 2008; 38:43-52; PMID:18343155; http://dx.doi.org/10.1016/j.mcn.2008.01.013.
39. Ment LR, Stewart WB, Scaramuzzino D, Madri JA. An in vitro three-dimensional coculture model of cerebral microvascular angiogenesis and differentiation. In Vitro Cell Dev Biol Anim 1997; 33:684-91; PMID:9358284; http://dx.doi.org/10.1007/s11626-997-0126-y.
40. Gnanaguru G, Brunken WJ. The cell-matrix interface: a possible target for treating retinal vascular related pathologies. J Ophthalmic Vis Res 2012; 7:316-27; PMID:23503323.
41. Mustafa DAN, Burgers PC, Dekker LJ, Charif H, Titulaer MK, Smitt PAES, Luider TM, Kros JM. Identification of glioma neovascularization-related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels. Mol Cell Proteomics 2007; 6:1147-57; PMID:17360931; http://dx.doi.org/10.1074/mcp.M600295-MCP200.
42. Chiu C-H, Chou C-W, Takada S, Liu Y-W. Development and fibronectin signaling requirements of the zebrafish interrenal vessel. PLoS One 2012; 7:e43040; PMID:22937010; http://dx.doi.org/10.1371/journal.pone.0043040.
43. Wu MH, Ustinova E, Granger HJ. Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J Physiol 2001; 532:785-91; PMID:11313446; http://dx.doi.org/10.1111/j.1469-7793.2001.0785e.x.
44. Li R, Ren M, Chen N, Luo M, Zhang Z, Wu J. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. PLoS One 2012; 7:e37195; PMID:22606350; http://dx.doi.org/10.1371/journal.pone.0037195.
45. Tyagi N, Roberts AM, Dean WL, Tyagi SC, Lominadze D. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 2008; 307:13-22; PMID:17849175; http://dx.doi.org/10.1007/s11010-007-9579-2.
46. Hanks SK, Polte TR. Signaling through focal adhesion kinase. Bioessays 1997; 19:137-45; PMID:9046243; http://dx.doi.org/10.1002/bies.950190208.
47. Infusino GA, Jacobson JR. Endothelial FAK as a therapeutic target in disease. Microvasc Res 2012; 83:89-96; PMID:22008516; http://dx.doi.org/10.1016/j.mvr.2011.09.011.
48. Ghatak S, Morgner J, Wickstrom SA. ILK: a pseudokinase with a unique function in the integrin-actin linkage. Biochem Soc Trans 2013; 41:995-1001; PMID:23863169; http://dx.doi.org/10.1042/BST20130062.
49. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, Sigismund S, Ristagno G, Maddaluno L, Koh GY, Franco D, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 2012; 3:1208; PMID:23169049; http://dx.doi.org/10.1038/ncomms2199.
50. Sangrar W, Gao Y, Scott M, Truesdell P, Greer PA. Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrinmediated cell adhesion. Mol Cell Biol 2007; 27:6140-52; PMID:17606629; http://dx.doi.org/10.1128/MCB.01744-06.
51. Yang X, Dutta U, Shaw LM. SHP2 mediates the localized activation of Fyn downstream of the alpha6-beta4 integrin to promote carcinoma invasion. Mol Cell Biol 2010; 30:5306-17; PMID:20855525; http://dx.doi.org/10.1128/MCB.00326-10.
52. Lee YH, Kayyali US, Sousa AM, Rajan T, Lechleider RJ, Day RM. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinaseSrc. Am J Respir Cell Mol Biol 2007; 37:485-93; PMID:17585111; http://dx.doi.org/10.1165/rcmb.2006-0439OC.
53. Jean C, Chen XL, Nam JO, Tancioni I, Uryu S, Lawson C, Ward KK, Walsh CT, Miller NL, Ghassemian M, et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J Cell Biol 2014; 204:247-63; PMID:24446483; http://dx.doi.org/10.1083/jcb.201307067.
54. Zhang G, Xu S, Qian Y, He P. Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules. Am J Physiol Heart Circ Physiol 2010; 299: H1494-504; PMID:20729401; http://dx.doi.org/10.1152/ajpheart.00462.2010.
55. Mehta D, Tiruppathi C, Sandoval R, Minshall RD, Holinstat M, Malik AB. Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier function. J Physiol 2002; 539:779-89; PMID:11897849; http://dx.doi.org/10.1113/jphysiol.2001.013289.
56. Birukova AA, Chatchavalvanich S, Oskolkova O, Bochkov VN, Birukov KG. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection. Microvasc Res 2007; 73:173-81; PMID:17292425; http://dx.doi.org/10.1016/j.mvr.2006.12.004.
57. Birukova AA, Arce FT, Moldobaeva N, Dudek SM, Garcia JG, Lal R, Birukov KG. Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: atomic force microscopy force mapping of pulmonary endothelial monolayer. Nanomedicine 2009; 5:30-41; PMID:18824415; http://dx.doi.org/10.1016/j.nano.2008.07.002.
58. Birukova AA, Cokic I, Moldobaeva N, Birukov KG. Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. Am J Respir Cell Mol Biol 2009; 40:99-107; PMID:18664639; http://dx.doi.org/10.1165/rcmb.2008-0099OC.
59. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006; 281:34381-93; PMID:16963454; http://dx.doi.org/10.1074/jbc.M603680200.
60. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008; 14:25-36; PMID:18194650; http://dx.doi.org/10.1016/j.devcel.2007.10.019.
61. Gawlak G, Tian Y, O’Donnell JJ, 3rd, Tian X, Birukova AA, Birukov KG. Paxillin mediates stretchinduced Rho signaling and endothelial permeability via assembly of paxillin-p4244MAPK-GEF-H1 complex. Faseb J 2014; 28:3249-60; PMID:24706358; http://dx.doi.org/10.1096/fj.13-245142.
62. Call GS, Chung JY, Davis JA, Price BD, Primavera TS, Thomson NC, Wagner MV, Hansen MD. Zyxin phosphorylation at serine 142 modulates the zyxin head-tail interaction to alter cell-cell adhesion. Biochem Biophys Res Commun 2011; 404:780-4; PMID:21168386; http://dx.doi.org/10.1016/j. bbrc.2010.12.058.
63. Nieset JE, Redfield AR, Jin F, Knudsen KA, Johnson KR, Wheelock MJ. Characterization of the interactions of alpha-catenin with alpha-actinin and beta-cateninplakoglobin. J Cell Sci 1997; 110 (Pt 8):1013-22; PMID:9152027.
64. Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C. Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol 2007; 179:1043-57; PMID:18056416; http://dx.doi.org/10.1083/jcb.200703036.
65. Mierke CT, Kollmannsberger P, Zitterbart DP, Smith J, Fabry B, Goldmann WH. Mechano-coupling and regulation of contractility by the vinculin tail domain. Biophys J 2008; 94:661-70; PMID:17890382; http://dx.doi.org/10.1529/biophysj.107.108472.
66. Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. J Cell Biol 2012; 196:641-52; PMID:22391038; http://dx.doi.org/10.1083/jcb.201108120.
67. Davenpeck KL, Sterbinsky SA, Bochner BS. Rat neutrophils express alpha4 and beta1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAd-CAM-1). Blood 1998; 91:2341-6; PMID:9516132.
68. Barringhaus KG, Phillips JW, Thatte JS, Sanders JM, Czarnik AC, Bennett DK, Ley KF, Sarembock IJ. Alpha4beta1 integrin (VLA-4) blockade attenuates both early and late leukocyte recruitment and neointimal growth following carotid injury in apolipoprotein E (–) mice. J Vasc Res 2004; 41:252-60; PMID:15153775; http://dx.doi.org/10.1159/000078646.
69. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res 2000; 87:153-9; PMID:10904000; http://dx.doi.org/10.1161/01.RES.87.2.153.
70. Sanz MJ, Marinova-Mutafchieva L, Green P, Lobb RR, Feldmann M, Nourshargh S. IL-4-induced eosinophil accumulation in rat skin is dependent on endogenous TNF-alpha and alpha 4 integrinVCAM-1 adhesion pathways. J Immunol 1998; 160:5637-45; PMID:9605170.
71. Madri JA, Graesser D, Haas T. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol 1996; 74:749-57; PMID:9164645; http://dx.doi.org/10.1139/o96-082.
72. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995; 12:624-32; PMID:7539273; http://dx.doi.org/10.1165/ajrcmb.12.6.7539273.
73. Tsuzuki S, Toyama-Sorimachi N, Kitamura F, Tobita Y, Miyasaka M. FK506 (tacrolimus) inhibits extravasation of lymphoid cells by abrogating VLA-4VCAM-1 mediated transendothelial migration. FEBS Lett 1998; 430:414-8; PMID:9688583; http://dx.doi.org/10.1016/S0014-5793(98)00703-0.
74. Muller WA. Mechanisms of transendothelial migration of leukocytes. Circ Res 2009; 105:223-30; PMID:19644057; http://dx.doi.org/10.1161/CIRCRESAHA.109.200717.
75. Arcangeli ML, Frontera V, Aurrand-Lions M. Function of junctional adhesion molecules (JAMs) in leukocyte migration and homeostasis. Arch Immunol Ther Exp (Warsz) 2013; 61:15-23; PMID:22940878; http://dx.doi.org/10.1007/s00005-012-0199-5.
76. Marcos-Ramiro B, Garcia-Weber D, Millan J. TNFinduced endothelial barrier disruption: beyond actin and Rho. Thromb Haemost 2014; 112: 1088–1102 PMID:25078148 http://dx.doi.org/10.1160/TH14-04-0299.
77. Patibandla PK, Tyagi N, Dean WL, Tyagi SC, Roberts AM, Lominadze D. Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 2009; 221:195-203; PMID:19507189; http://dx.doi.org/10.1002/jcp.21845.
78. Sumagin R, Kuebel JM, Sarelius IH. Leukocyte rolling and adhesion both contribute to regulation of microvascular permeability to albumin via ligation ofICAM-1. Am J Physiol Cell Physiol 2011; 301: C804-13; PMID:21653902; http://dx.doi.org/10.1152/ajpcell.00135.2011.
79. Clark PR, Manes TD, Pober JS, Kluger MS. Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J Invest Dermatol 2007; 127:762-74; PMID:17195014; http://dx.doi.org/10.1038/sj. jid.5700670.
80. van Buul JD, van Rijssel J, van Alphen FP, van Stalborch AM, Mul EP, Hordijk PL. ICAM-1 clustering on endothelial cells recruits VCAM-1. J Biomed Biotechnol 2010; 2010:120328; PMID:20300427; http://dx.doi.org/10.1155/2010/120328.
81. Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 2000; 156:1733-9; PMID:10793084; http://dx.doi.org/10.1016/S0002-9440(10)65044-4.
82. Sumagin R, Sarelius IH. TNF-alpha activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 2006; 291: H2116-25; PMID:16766643; http://dx.doi.org/10.1152/ajpheart.00248.2006.
83. Gaber MW, Yuan H, Killmar JT, Naimark MD, Kiani MF, Merchant TE. An intravital microscopy study of radiation-induced changes in permeability and leukocyte-endothelial cell interactions in the microvessels of the rat pia mater and cremaster muscle. Brain Res Brain Res Protoc 2004; 13:1-10; PMID:15063835; http://dx.doi.org/10.1016/j.brainresprot.2003.11.005.
84. Sumagin R, Lomakina E, Sarelius IH. Leukocyteendothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am J Physiol Heart Circ Physiol 2008; 295:H969-H77; PMID:18641276; http://dx.doi.org/10.1152/ajpheart.00400.2008.
85. Greenwood J, Amos CL, Walters CE, Couraud PO, Lyck R, Engelhardt B, Adamson P. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol 2003; 171: 2099-108; PMID:12902516; http://dx.doi.org/10.4049/jimmunol.171.4.2099.
86. Sans E, Delachanal E, Duperray A. Analysis of the roles of ICAM-1 in neutrophil transmigration using a reconstituted mammalian cell expression model: implication of ICAM-1 cytoplasmic domain and Rho-dependent signaling pathway. J Immunol 2001; 166:544-51; PMID:11123335; http://dx.doi.org/10.4049/jimmunol.166.1.544.
87. Sumagin R, Sarelius IH. Intercellular adhesion molecule-1 enrichment near tricellular endothelial junctions is preferentially associated with leukocyte transmigration and signals for reorganization of these junctions to accommodate leukocyte passage. J Immunol 2010; 184:5242-52; PMID:20363969; http://dx.doi.org/10.4049/jimmunol.0903319.
88. Schaefer A, Te Riet J, Ritz K, Hoogenboezem M, Anthony EC, Mul FP, de Vries CJ, Daemen MJ, Figdor CG, van Buul JD, et al. Actin-binding proteins differentially regulate endothelial cell stiffness, ICAM-1 function and neutrophil transmigration. J Cell Sci 2014; 127(Pt 20):4470-82; PMID:25107367; http://dx.doi.org/10.1242/jcs.154708.
89. Vestweber D, Zeuschner D, Rottner K, Schnoor M. Cortactin regulates the activity of small GTPases and ICAM-1 clustering in endothelium: Implications for the formation of docking structures. Tissue Barriers 2013; 1:e23862; PMID:24665381; http://dx.doi.org/10.4161/tisb.23862.
90. Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, Sanchez-Madrid F. Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 2002; 157:1233-45; PMID:12082081; http://dx.doi.org/10.1083/jcb.200112126.
91. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993; 120:1371-80; PMID:8449983; http://dx.doi.org/10.1083/jcb.120.6.1371.
92. Wang Q, Doerschuk CM. The signaling pathways induced by neutrophil-endothelial cell adhesion. Antioxid Redox Signal 2002; 4:39-47; PMID:11970842; http://dx.doi.org/10.1089/152308602753625843.
93. Hu G, Vogel SM, Schwartz DE, Malik AB, Minshall RD. Intercellular adhesion molecule-1-dependent neutrophil adhesion to endothelial cells induces caveolae-mediated pulmonary vascular hyperpermeability. Circ Res 2008; 102:e120-31; PMID:18511851; http://dx.doi.org/10.1161/CIRCRESAHA.107.167486.
94. Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src-and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 2007; 179:4053-64; PMID:17785844; http://dx.doi.org/10.4049/jimmunol.179.6.4053.
95. van Wetering S, van den Berk N, van Buul JD, Mul FP, Lommerse I, Mous R, ten Klooster JP, Zwaginga JJ, Hordijk PL. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol 2003; 285: C343-52; PMID:12700137; http://dx.doi.org/10.1152/ajpcell.00048.2003.
96. Vockel M, Vestweber D. How T cells trigger the dissociation of the endothelial receptor phosphatase VEPTP from VE-cadherin. Blood 2013; 122:2512-22; PMID:23908467; http://dx.doi.org/10.1182/blood-2013-04-499228.
97. Wei H, Fang L, Song J, Chatterjee S. Statin-inhibited endothelial permeability could be associated with its effect on PECAM-1 in endothelial cells. FEBS Lett 2005; 579:1272-8; PMID:15710425; http://dx.doi.org/10.1016/j.febslet.2005.01.020.
98. Sharma P, Templin T, Grabham P. Short term effects of gamma radiation on endothelial barrier function: uncoupling of PECAM-1. Microvasc Res 2013; 86:11-20; PMID:23220351; http://dx.doi.org/10.1016/j.mvr.2012.11.007.
99. Fernandez-Martin L, Marcos-Ramiro B, Bigarella CL, Graupera M, Cain RJ, Reglero-Real N, Jimenez A, Cernuda-Morollon E, Correas I, Cox S, et al. Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 2012; 32:e90-102; PMID:22723439; http://dx.doi.org/10.1161/ATVBAHA.112.252080.
100. Wong D, Prameya R, Dorovini-Zis K. Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J Neuroimmunol 2007; 184:136-48; PMID:17291598; http://dx.doi.org/10.1016/j.jneuroim.2006.12.003.
101. Turegun M, Gudemez E, Newman P, Zins J, Siemionow M. Blockade of platelet endothelial cell adhesion molecule-1 (PECAM-1) protects against ischemiareperfusion injury in muscle flaps at microcirculatory level. Plast Reconstr Surg 1999; 104:1033-40; PMID:10654744; http://dx.doi.org/10.1097/00006534-199909020-00021.
102. Lishnevsky M, Young LC, Woods SJ, Groshong SD, Basaraba RJ, Gilchrist JM, Higgins DM, Gonzalez-Juarrero M, Bass TA, Muller WA, et al. Microhemorrhage is an early event in the pulmonary fibrotic disease of PECAM-1 deficient FVBn mice. Exp Mol Pathol 2014; 97:128-36; PMID:24972347; http://dx doi.org/10.1016/j.yexmp.2014.06.008.
103. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman PJ. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol 2005; 288:H159-64; PMID:15319204; http://dx.doi.org/10.1152/ajpheart.00500.2004.
104. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, Engelhardt B, Madri JA. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 2002; 109:383-92; PMID:11827998; http://dx.doi.org/10.1172/JCI0213595.
105. Pumphrey NJ, Taylor V, Freeman S, Douglas MR, Bradfield PF, Young SP, Lord JM, Wakelam MJ, Bird IN, Salmon M, et al. Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1CD31. FEBS Lett 1999; 450:77-83; PMID:10350061; http://dx.doi.org/10.1016/S0014-5793(99)00446-9.
106. Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 2005; 118:4103-11; PMID:16118242; http://dx.doi.org/10.1242/jcs.02541.
107. Yeh JC, Otte LA, Frangos JA. Regulation of G protein-coupled receptor activities by the platelet-endothelial cell adhesion molecule, PECAM-1. Biochemistry 2008; 47:9029-39; PMID:18672896; http://dx.doi.org/10.1021/bi8003846.
108. Gratzinger D, Barreuther M, Madri JA. Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif. Biochem Biophys Res Commun 2003; 301:243-9; PMID:12535670; http://dx.doi.org/10.1016/S0006-291X(02)02982-0.
109. Zebda N, Tian Y, Tian X, Gawlak G, Higginbotham K, Reynolds AB, Birukova AA, Birukov KG. Interaction of p190RhoGAP with C-terminal domain of p120-catenin modulates endothelial cytoskeleton and permeability. J Biol Chem 2013; 288:18290-9; PMID:23653363; http://dx.doi.org/10.1074/jbc. M112.432757.
110. Anastasiadis PZ, Reynolds AB. The p120 catenin family: complex roles in adhesion, signaling and cancer. J Cell Sci 2000; 113 (Pt 8):1319-34; PMID:10725216.
111. Alcaide P, Martinelli R, Newton G, Williams MR, Adam A, Vincent PA, Luscinskas FW. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation. Am J Physiol Cell Physiol 2012; 303:C385-95; PMID:22648953; http://dx.doi.org/10.1152/ajpcell.00126.2012.
112. Noren NK, Liu BP, Burridge K, Kreft B. p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 2000; 150:567-80; PMID:10931868; http://dx.doi.org/10.1083/jcb.150.3.567.
113. Beckers CM, Garcia-Vallejo JJ, van Hinsbergh VW, van Nieuw Amerongen GP. Nuclear targeting of {beta}-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction. Cardiovasc Res 2008; 79:679-88; PMID:18490349; http://dx.doi.org/10.1093/cvr/cvn127.
114. Zhu YT, Chen HC, Chen SY, Tseng SC. Nuclear p120 catenin unlocks mitotic block of contact-inhibited human corneal endothelial monolayers without disrupting adherent junctions. J Cell Sci 2012; 125:3636-48; PMID:22505615; http://dx.doi.org/10.1242/jcs.103267.
115. Zhang J, O’Donnell JJ 3rd, Holian O, Vincent PA, Kim KS, Lum H. P120 catenin represses transcriptional activity through Kaiso in endothelial cells. Microvasc Res 2010; 80:233-9; PMID:20382170; http://dx.doi.org/10.1016/j.mvr.2010.04.001116.
116. O’Donnell JJ 3rd, Zhuge Y, Holian O, Cheng F, Thomas LL, Forsyth CB, Lum H. Loss of p120 catenin upregulates transcription of pro-inflammatory adhesion molecules in human endothelial cells. Microvasc Res 2011; 82:105-12; PMID:Can’t; http://dx.doi.org/10.1016/j.mvr.2011.04.008.
117. Kikuchi A, Kishida S, Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 2006; 38:1-10; PMID:16520547; http://dx.doi.org/10.1038/emm.2006.1.
118. Clevers H. Wntbeta-catenin signaling in development and disease. Cell 2006; 127:469-80; PMID:17081971; http://dx.doi.org/10.1016/j.cell.2006.10.018.
119. Goodwin A, Kitajewski J, D’Amore P. Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not. Growth Factors 2007; 25:25-32; PMID:17454147; http://dx.doi.org/10.1080/08977190701272933.
120. Wright M, Aikawa M, Szeto W, Papkoff J. Identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem Biophys Res Commun 1999; 263:384-8; PMID:10491302; http://dx.doi.org/10.1006/bbrc.1999.1344.
121. Masckauchan T, Shawber C, Funahashi Y, Li C, Kitajewski J. Wntbeta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 2005; 8:43-51; PMID:16132617; http://dx.doi.org/10.1007/s10456-005-5612-9.
122. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000; 59:333-7; PMID:10759189.
123. Birukova AA, Malyukova I, Poroyko V, Birukov KG. Paxillin-beta-catenin interactions are involved in RacCdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2007; 293:L199-211; PMID:17513457; http://dx.doi.org/10.1152/ajplung.00020.2007.
124. Tinsley JH, Ustinova EE, Xu W, Yuan SY. Src-dependent, neutrophil-mediated vascular hyperpermeability and beta-catenin modification. Am J Physiol Cell Physiol 2002; 283:C1745-51; PMID:12388068; http://dx.doi.org/10.1152/ajpcell.00230.2002.
125. Jang MW, Yun SP, Park JH, Ryu JM, Lee JH, Han HJ. Cooperation of Epac1Rap1Akt and PKA in prostaglandin E(2) -induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression. J Cell Physiol 2012; 227:3756-67; PMID:22378492; http://dx.doi.org/10.1002/jcp.24084.
126. Marin N, Zamorano P, Carrasco R, Mujica P, Gonzalez FG, Quezada C, Meininger CJ, Boric MP, Duran WN, Sanchez FA. S-Nitrosation of beta-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability. Circ Res 2012; 111: 553-63; PMID:22777005; http://dx.doi.org/10.1161/CIRCRESAHA.112.274548.
127. Gonzalez D, Rojas A, Herrera MB, Conlan RS. iNOS activation regulates beta-catenin association with its partners in endothelial cells. PLoS One 2012; 7: e52964; PMID:23285236; http://dx.doi.org/10.1371/journal.pone.0052964.
128. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 2008; 10:923-34; PMID:18604199; http://dx.doi.org/10.1038/ncb1752.
129. Glading AJ, Ginsberg MH. Rap1 and its effector KRIT1CCM1 regulate beta-catenin signaling. Dis Model Mech 2010; 3:73-83; PMID:20007487; http://dx.doi.org/10.1242/dmm.003293.
130. Corr M, Lerman I, Keubel JM, Ronacher L, Misra R, Lund F, Sarelius IH, Glading AJ. Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo. Arterioscler Thromb Vasc Biol 2012; 32:2702-10; PMID:22922958; http://dx.doi.org/10.1161/ATVBAHA.112.300115.
131. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, Ben-Ze’ev A. The cyclin D1 gene is a target of the beta-cateninLEF-1 pathway. Proc Natl Acad Sci U S A 1999; 96:5522-7; PMID:10318916; http://dx.doi.org/10.1073/pnas.96.10.5522.
132. Haertel-Wiesmann M, Liang Y, Fantl WJ, Williams LT. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 2000; 275:32046-51; PMID:10884377; http://dx.doi.org/10.1074/jbc.M000074200